GEORGE NORTHRUP: Open Payments
NPI 1629006507 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$908 in 39 payments from 13 companies in 2025. Trend: 2023 $1,406 · 2024 $1,297 · 2025 $908
Food & beverage: $908
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $231 |
| Vanda Pharmaceuticals Inc. | 4 | $114 |
| ABBVIE INC. | 5 | $111 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Bausch Health US, LLC | 3 | $68 |
| Indivior Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Janssen Pharmaceuticals, Inc | 2 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
Products named: INGREZZA, VRAYLAR, HETLIOZ, Auvelity, SUBLOCADE, APLENZIN, COBENFY, REXULTI.
Industry payments across FL — which companies pay providers there.
